Pfizer On The Prowl For Generics
Only weeks after announcing its Wyeth acquisition, Pfizer is stepping up its profile in the generics world, looking for branded and commodity opportunities.
Only weeks after announcing its Wyeth acquisition, Pfizer is stepping up its profile in the generics world, looking for branded and commodity opportunities.